Member Info for Dibs61

Means another placing is on the way - thats the way the market has read it - and highly fanciful to imagine it would be at a premium. Look at the history. Paying fees with shares means they have no cash to pay the bill. This truly has turned out to be a car crash of a company and to a large degree due to poor management.

ODX just posted this on Facebook: We put a lot of planning, time and effort into our training materials. Part of this process involves developing tools that will help to support health workers to use our tests accurately. "An example of many hours of conceptualizing, discussing, designing, trying, testing and making changes. These tools evolve the more experience we get on what works for adult education and training in the field #RDTs #diagnostics #HIV #Malaria #VISITECTCD4 #VISITECTMalaria #training #healthcare #services" Clearly they are putting a LOT of work into making the CD4 Visitect project work

Its showing .14 for me? SP can always go lower BUT this is now valued at just the OLD VS asset valuation with nothing else so hopefully a bit of support there

BOD and major shareholders are showing huge confidence in this company with some major individual investments in the recent fundraising. Five members of the board investing from £9,600 to £200,000 plus major shareholders Richard Sneller and L&G pumping in hundreds of thousands of pounds. And if you research this company properly you will start to understand why! DYOR

Things are about to become very interesting here on a few fronts.

Comment by Europa CEO: We note the imminent start of drilling operations in FEL 2/14 some 100km south of LO 16/19. The outcome of this well is not only relevant to our Cretaceous fan and Paleocene prospects and leads in the basin, it also has the potential to de-risk all four of our South Porcupine licences across which we have identified gross mean un-risked prospective resources of over 4 billion barrels oil equivalent, half of which have been independently audited by a Competent Person." It will have a similar effect on PET.....

Drilling spud status imminent at massive Druid/Dromberg well. Big excitement building over on PVR board. I see PET as a great alternative way to play this drill. Especially as they will also be releasing their own 3D seismic in the Porcupine in Q3. Very interesting few months ahead could see this double/triple easily with newsflow pending

Building sale raises £700k. All useful extra cash to go into the company's accelerated growth strategy

http://email.edisoninvestment.com/2PWO-HTSJ-F52GNE3E79/cr.aspx

A 'blue' day here :0

I won't be selling any shares I get in the Open Offer mate. It's a long term hold for sure here.

Hehe yes indeed.... Having read both the final results and placing RNS's I believe we should see a more regular newsflow in the next year because there are quite a number of different projects/products on the boil now. The Omega board are typically downplaying (imo) the significance of some of the initiatives currently being progressed. Very exciting times

Best day here for over a month. Been tough to see this slump from its highs around 27p but Finncap have raised their SP target to 30p (first time they've done that in 3 years). There are some major positives to be taken from this fundraising: 1. Uncertainty about cash funding for expansion is now removed. 2. We know they now have what they need for CD4 commercialisation 3. Major investors like Richard Sneller and Legal & General have backed the fundraising heavily 4. Directors have all put their hands in their pockets and backed it 5. Accelerated Growth potential across ALL lines of business 6. There is NO bad news on CD4 as I feared and we are on track fro product launch late 2017 Much happier now than this time last week!

Yep me too. Taken up mine in full.

Last of the big spenders me... ;)

A blue day at last. The first in three weeks. Three weeks. Been an unbelievably shocking run on the SP so thankful for small mercies. Good job this is a long night term investment for me regardless of short term machinations.

Looks like someone is busily mopping up all the shares this morning from yesterday's sell off.

About bloody time. First up day since 31st May. Just a thought, could the market be worrying about increased capital expenditure required for the 'accelerated growth strategy' the company has spoken about? Screaming buy at this level imo

Entirely expected but 1.3p? Ouch

I know I'm beginning to sound like one but this now has a MC £57.7m with something like £50-53m in the bank by my estimation. This means the valuation put on Reneurons assets eg.IP plus clinical trial progress is roughly £4-7m!!! I see the very worst of AIM dog stocks with bigger valuations than that?!